查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1998700

心房顫動治療設備市場：商業機會、成長要素、產業趨勢分析及 2026-2035 年預測。

Atrial Fibrillation Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035
出版日期: | 出版商: Global Market Insights Inc. | 英文 125 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025 年全球心房顫動治療設備市場規模預估為 129 億美元，預計到 2035 年將達到 402 億美元，年複合成長率為 12.2%。

心房顫動設備市場-IMG1

心房顫動治療設備的持續技術創新、心房顫動盛行率的上升、心導管電氣燒灼術手術的日益普及以及人們對早期診斷和治療意識的提高，共同推動了市場擴張。心房顫動治療設備，例如消融導管、植入式心臟監測器、心律調節器和去心房顫動，旨在恢復正常心率、預防中風並緩解心房顫動相關症狀。公共衛生宣傳活動和患者教育計畫正在推廣早期發現和及時干預，從而增加了對診斷和監測設備的需求。微創手術、穿戴式和遠端監測技術以及混合治療方法的日益普及，進一步加速了市場成長。能量輸送系統、精準標靶和設備小型化的持續創新，正在拓展心房顫動的治療選擇並改善治療效果。

市場範圍
開始年份 2025
預測期 2026-2035
上市時的市場規模 129億美元
預測金額 402億美元
複合年成長率 12.2%

至2025年，電生理消融導管市佔率將達到30.6%，在導管消融手術中扮演核心角色。這些器械能夠實現精準的病灶形成、提高組織標靶精度並提升手術成功率，使其成為電生理醫師的首選。灌注導管尖端、接觸力感測技術和增強型能量輸送系統等創新技術正在提高病患安全性、提升手術效率、縮短治療時間，並促進其進一步普及應用。

預計到2025年，醫院市場將佔據43.7%的佔有率，到2035年將達到178億美元。這項需求主要由醫院內專門的心房顫動治療中心推動，這些中心需要配備全面的醫療設備，用於診斷、治療和病患監測。認證項目和品質改進計劃正在促進醫院採購先進的房顫治療設備，並提高市場滲透率。

預計到2025年，北美心房顫動治療設備市佔率將達到40.6%。這一成長主要受心房顫動高發生率、人口老化以及高血壓、糖尿病和肥胖等心血管危險因子發病率上升的推動。該地區高昂的醫療費用支出支持了對先進心房顫動技術的投資，包括消融導管、心律調節器和診斷設備。醫療機構對創新解決方案的早期應用，以及人均心臟護理支出，進一步促進了該地區市場的成長。

目錄

第1章：調查方法

  • 研究途徑
  • 品質改進計劃
    • GMI人工智慧政策和資料完整性計劃
      • 資訊來源一致性通訊協定
  • 調查過程和可靠性評分
    • 調查過程的組成部分
    • 評分組成部分
  • 數據收集
    • 主要來源部分列表
  • 資料探勘資訊來源
    • 付費資訊來源
      • 區域資訊來源
  • 基本估算和計算方法
    • 每種方法中基準年的計算
  • 預測模型
    • 量化市場影響分析
      • 生長參數對預測的數學影響
  • 關於調查透明度的補充信息
    • 資訊來源歸屬框架
    • 品質保證指標
    • 對信任的承諾

第2章執行摘要

第3章業界考察

  • 生態系分析
  • 影響產業的因素
    • 促進因素
      • 先進技術的高普及率和先進醫療基礎設施的發展
      • 心血管疾病盛行率增加
      • 有利的贖回環境
      • 風濕性心臟瓣膜疾病盛行率增加
    • 產業潛在風險與挑戰
      • 心房顫動治療設備高成本
      • 開發中國家對先進醫療技術的認知度較低
    • 市場機遇
      • 微創和導管介入治療方法的擴展
  • 成長潛力分析
  • 監理情勢
    • 北美洲
    • 歐洲
    • 亞太地區
  • 技術趨勢（基於初步調查）
    • 當前技術趨勢
    • 新興技術
  • 未來市場趨勢（基於初步研究）
    • 世界
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 區域心導管電氣燒灼術中心，2022-2025 年
  • 專利分析
  • 價格分析（2025 年）（基於初步調查）
  • 客戶洞察
  • 人工智慧和生成式人工智慧對市場的影響
  • 波特五力分析
  • PESTEL 分析
  • 差距分析

第4章 競爭情勢

  • 介紹
  • 企業矩陣分析
  • 企業市佔率分析
    • 世界
    • 北美洲
    • 歐洲
    • 亞太地區
  • 競爭定位矩陣
  • 主要市場公司的競爭分析
  • 主要進展
    • 併購
    • 夥伴關係與合作
    • 新產品類型發布
    • 業務拓展計劃

第5章 市場估價與預測：依產品分類，2022-2035年

  • 電生理消融導管
    • 射頻（RF）
    • 雷射
    • 冷凍消融術
    • 超音波
    • 微波
    • 其他電生理消融導管
  • 心臟監測儀或植入式循環記錄儀
  • 電生理診斷導管
    • 進階標測導管
    • 可插入導管
    • 固定彎曲導管
  • 地圖繪製與記錄系統
  • 存取裝置
  • 心內超音波心動圖（ICE）
  • 左心耳封堵器
  • 其他產品

第6章 市場估算與預測：依最終用途分類，2022-2035年

  • 醫院
  • 心臟中心
  • 門診手術中心
  • 其他最終用戶

第7章 市場估計與預測：依地區分類，2022-2035年

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第8章：公司簡介

  • Abbott
  • Acutus Medical
  • AtriCure
  • Biotronik
  • Boston Scientific Corporation
  • CardioFocus
  • CathRx
  • Hansen Medical
  • Imricor
  • Johnson and Johnson
  • Medtronic
  • MicroPort Scientific Corporation
  • OSYPKA MEDICAL
  • Stryker Corporation
  • Synaptic Medical
簡介目錄
Product Code: 3165

The Global Atrial Fibrillation Devices Market was valued at USD 12.9 billion in 2025 and is estimated to grow at a CAGR of 12.2% to reach USD 40.2 billion by 2035.

Atrial Fibrillation Devices Market - IMG1

Market expansion is driven by ongoing technological innovations in AF devices, the rising prevalence of atrial fibrillation, increasing adoption of cardiac ablation procedures, and heightened awareness about early diagnosis and management. AF devices, including ablation catheters, implantable cardiac monitors, pacemakers, and defibrillators, are designed to restore normal heart rhythm, prevent stroke, and reduce AF-related symptoms. Public health campaigns and patient education programs are promoting early detection and timely intervention, boosting demand for diagnostic and monitoring tools. Minimally invasive procedures, wearable and remote monitoring technologies, and hybrid treatment approaches are gaining traction, further accelerating market growth. Continuous innovation in energy delivery systems, precision targeting, and device miniaturization is expanding AF treatment options and improving procedural outcomes.

Market Scope
Start Year2025
Forecast Year2026-2035
Start Value$12.9 Billion
Forecast Value$40.2 Billion
CAGR12.2%

The EP ablation catheters segment held a 30.6% share in 2025 owing to their central role in catheter-based ablation procedures. These devices allow precise lesion formation, improved tissue targeting, and higher procedural success rates, making them the preferred choice among electrophysiologists. Innovations such as irrigated tip catheters, contact force-sensing technology, and enhanced energy delivery systems are improving patient safety, increasing procedural efficiency, reducing treatment time, and driving further adoption.

The hospitals segment captured a 43.7% share in 2025 and is expected to reach USD 17.8 billion by 2035. Demand is being fueled by specialized AF treatment centers within hospitals, which require comprehensive device inventories for diagnosis, treatment, and patient monitoring. Accreditation programs and quality improvement initiatives motivate hospitals to procure advanced AF devices, increasing market uptake.

North America Atrial Fibrillation Devices Market held a 40.6% share in 2025, driven by a high prevalence of atrial fibrillation, an aging population, and the rising incidence of cardiovascular risk factors such as hypertension, diabetes, and obesity. The region's substantial healthcare expenditure supports investment in advanced AF technologies, including ablation catheters, pacemakers, and diagnostic devices. Early adoption of innovative solutions by healthcare providers, along with per capita spending on cardiac care, further strengthens regional growth.

Prominent players in the Global Atrial Fibrillation Devices Market include Abbott, Acutus Medical, AtriCure, Biotronik, Boston Scientific Corporation, CardioFocus, CathRx, Hansen Medical, Imricor, Johnson and Johnson, Medtronic, MicroPort Scientific Corporation, OSYPKA MEDICAL, Stryker Corporation, and Synaptic Medical. Key strategies adopted by companies in minimally invasive, energy-efficient, and precision ablation technologies; expanding product portfolios to include remote monitoring and wearable solutions; forming strategic partnerships with hospitals, clinics, and diagnostic centers; pursuing regulatory approvals and certifications to enter new markets; enhancing global distribution networks to improve accessibility; and implementing patient awareness campaigns to drive early diagnosis. Firms also focus on clinician training programs, after-sales service, and hybrid procedural solutions to strengthen their market footprint, build brand loyalty, and maintain competitive advantage.

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Research approach
  • 1.2 Quality commitments
    • 1.2.1 GMI AI policy & data integrity commitment
      • 1.2.1.1 Source consistency protocol
  • 1.3 Research trail & confidence scoring
    • 1.3.1 Research trail components
    • 1.3.2 Scoring components
  • 1.4 Data collection
    • 1.4.1 Partial list of primary sources
  • 1.5 Data mining sources
    • 1.5.1 Paid sources
      • 1.5.1.1 Sources, by region
  • 1.6 Base estimates and calculations
    • 1.6.1 Base year calculation for any one approach
  • 1.7 Forecast model
    • 1.7.1 Quantified market impact analysis
      • 1.7.1.1 Mathematical impact of growth parameters on forecast
  • 1.8 Research transparency addendum
    • 1.8.1 Source attribution framework
    • 1.8.2 Quality assurance metrics
    • 1.8.3 Our commitment to trust

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional trends
    • 2.2.2 Product trends
    • 2.2.3 End use trends
  • 2.3 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 High adoption rate of advanced technologies and presence of sophisticated healthcare infrastructure
      • 3.2.1.2 Increase in prevalence of cardiovascular diseases
      • 3.2.1.3 Favorable reimbursement scenario
      • 3.2.1.4 Rise in prevalence of rheumatic valvular heart diseases
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost associated with atrial fibrillation devices
      • 3.2.2.2 Lack of awareness regarding enhanced medical technologies in developing countries
    • 3.2.3 Market opportunities
      • 3.2.3.1 Expansion of minimally invasive and catheter-based therapies
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
  • 3.5 Technology landscape (Driven by Primary Research)
    • 3.5.1 Current technological trends
    • 3.5.2 Emerging technologies
  • 3.6 Future market trends (Driven by Primary Research)
  • 3.7 Atrial fibrillation devices market, 2022 -2035 (Units)
    • 3.7.1 Global
    • 3.7.2 North America
    • 3.7.3 Europe
    • 3.7.4 Asia Pacific
    • 3.7.5 Latin America
    • 3.7.6 MEA
  • 3.8 Catheter ablation centres, by region, 2022 - 2025
  • 3.9 Patent analysis
  • 3.10 Pricing analysis, 2025 (Driven by Primary Research)
  • 3.11 Customer insights
  • 3.12 Impact of AI and generative AI on the market
  • 3.13 Porter's analysis
  • 3.14 PESTEL analysis
  • 3.15 Gap analysis

Chapter 4 Competitive Landscape, 2025

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
    • 4.3.1 Global
    • 4.3.2 North America
    • 4.3.3 Europe
    • 4.3.4 Asia Pacific
  • 4.4 Competitive positioning matrix
  • 4.5 Competitive analysis of major market players
  • 4.6 Key developments
    • 4.6.1 Mergers & acquisitions
    • 4.6.2 Partnerships & collaborations
    • 4.6.3 New product type launches
    • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2022 - 2035 ($ Mn)

  • 5.1 Key trends
  • 5.2 EP ablation catheters
    • 5.2.1 Radiofrequency (RF)
    • 5.2.2 Laser
    • 5.2.3 Cryoablation
    • 5.2.4 Ultrasound
    • 5.2.5 Microwave
    • 5.2.6 Other EP ablation catheters
  • 5.3 Cardiac monitors or implantable loop recorder
  • 5.4 EP diagnostic catheters
    • 5.4.1 Advanced mapping catheters
    • 5.4.2 Steerable catheters
    • 5.4.3 Fixed curve catheters
  • 5.5 Mapping and recording systems
  • 5.6 Access devices
  • 5.7 Intracardiac echocardiography (ICE)
  • 5.8 Left atrial appendage (LAA) closure devices
  • 5.9 Other products

Chapter 6 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

  • 6.1 Key trends
  • 6.2 Hospitals
  • 6.3 Cardiac centers
  • 6.4 Ambulatory surgical centers
  • 6.5 Other end-users

Chapter 7 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

  • 7.1 Key trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Spain
    • 7.3.5 Italy
    • 7.3.6 Netherlands
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 South Korea
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
  • 7.6 Middle East and Africa
    • 7.6.1 South Africa
    • 7.6.2 Saudi Arabia
    • 7.6.3 UAE

Chapter 8 Company Profiles

  • 8.1 Abbott
  • 8.2 Acutus Medical
  • 8.3 AtriCure
  • 8.4 Biotronik
  • 8.5 Boston Scientific Corporation
  • 8.6 CardioFocus
  • 8.7 CathRx
  • 8.8 Hansen Medical
  • 8.9 Imricor
  • 8.10 Johnson and Johnson
  • 8.11 Medtronic
  • 8.12 MicroPort Scientific Corporation
  • 8.13 OSYPKA MEDICAL
  • 8.14 Stryker Corporation
  • 8.15 Synaptic Medical